Treatment of Systemic Sclerosis Associated Interstitial Lung Disease
Systemic sclerosis (SSc) is a systemic connective tissue disorder characterized by progressive skin and visceral organ fibrosis, vasculopathy, and immune dysregulation. Interstitial lung disease (ILD) is a common manifestation and major contributor to morbidity and mortality. Immunosuppression is us...
Main Authors: | Iris Yan Ki Tang, So Ho |
---|---|
Format: | Article |
Language: | English |
Published: |
World Scientific Publishing
2020-12-01
|
Series: | Journal of Clinical Rheumatology and Immunology |
Subjects: | |
Online Access: | http://www.worldscientific.com/doi/epdf/10.1142/S2661341720300050 |
Similar Items
-
Systemic Sclerosis-Associated Interstitial Lung Disease: Prevalence and Risk Factors
by: Dennis Tin Ho Chan, et al.
Published: (2023-07-01) -
Systemic Sclerosis Associated Interstitial Lung Disease: New Directions in Disease Management
by: Mehdi Mirsaeidi, et al.
Published: (2019-10-01) -
Management of Patients with Systemic Sclerosis-Associated Interstitial Lung Disease: A Focus on the Role of the Pharmacist
by: Farrell J, et al.
Published: (2023-05-01) -
Lung transplantation in connective tissue disease associated interstitial lung disease
by: Srinivas Rajagopala, et al.
Published: (2021-01-01) -
The Role of Bronchoalveolar Lavage in Systemic Sclerosis Interstitial Lung Disease: A Systematic Literature Review
by: Martina Orlandi, et al.
Published: (2022-12-01)